Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Non-Current Assets: 2021-2025

Historic Non-Current Assets for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $153.6 million.

  • Prime Medicine's Non-Current Assets rose 77.14% to $153.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.6 million, marking a year-over-year increase of 77.14%. This contributed to the annual value of $85.6 million for FY2024, which is 68.30% up from last year.
  • According to the latest figures from Q3 2025, Prime Medicine's Non-Current Assets is $153.6 million, which was down 2.61% from $157.7 million recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Non-Current Assets ranged from a high of $164.4 million in Q1 2025 and a low of $31.3 million during Q4 2021.
  • Over the past 3 years, Prime Medicine's median Non-Current Assets value was $86.7 million (recorded in 2024), while the average stood at $96.5 million.
  • In the last 5 years, Prime Medicine's Non-Current Assets surged by 103.65% in 2022 and then decreased by 20.13% in 2023.
  • Over the past 5 years, Prime Medicine's Non-Current Assets (Quarterly) stood at $31.3 million in 2021, then skyrocketed by 103.65% to $63.7 million in 2022, then dropped by 20.13% to $50.9 million in 2023, then skyrocketed by 68.30% to $85.6 million in 2024, then spiked by 77.14% to $153.6 million in 2025.
  • Its Non-Current Assets stands at $153.6 million for Q3 2025, versus $157.7 million for Q2 2025 and $164.4 million for Q1 2025.